José M González-Navajas Selected Research

José M González-Navajas Research Topics

Disease

20	Fibrosis (Cirrhosis) 01/2020 - 09/2006
8	Inflammation (Inflammations) 10/2019 - 02/2014
6	Peritonitis 01/2020 - 07/2007
5	Melanoma (Melanoma, Malignant) 02/2022 - 01/2015
5	Ascites 10/2019 - 09/2006
5	Crohn Disease (Crohn's Disease) 01/2019 - 02/2014
4	Bacterial Infections (Bacterial Infection) 01/2018 - 07/2007
3	Liver Diseases (Liver Disease) 06/2019 - 01/2015
3	Infections 10/2014 - 05/2007
2	Hepatic Encephalopathy 10/2019 - 01/2017
2	Necrosis 02/2014 - 01/2008
1	Neoplasms (Cancer) 01/2021
1	Endotoxemia 10/2019
1	End Stage Liver Disease 10/2019
1	Portal Hypertension 10/2019
1	Pancreatitis 05/2017
1	Disease Progression 05/2017
1	Sudden Infant Death (SID) 12/2016
1	Critical Illness (Critically Ill) 10/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2016
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 09/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2014
1	Virus Diseases (Viral Diseases) 01/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Colitis 02/2010

Drug/Important Bio-Agent (IBA)

10	Bacterial DNAIBA 01/2019 - 09/2006
8	Norfloxacin FDA Link 01/2020 - 09/2006
6	InflammasomesIBA 02/2022 - 01/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 09/2006
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 02/2010
3	Bacterial AntigensIBA 12/2018 - 07/2014
3	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2018 - 10/2014
3	CytokinesIBA 11/2017 - 03/2008
3	Phenobarbital (Luminal)FDA Link 10/2016 - 10/2014
3	EndotoxinsIBA 10/2014 - 07/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 01/2019
2	Interleukin-18 (Interleukin 18)IBA 05/2017 - 01/2015
2	AntigensIBA 01/2017 - 02/2016
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 09/2014
2	Biological ProductsIBA 07/2015 - 09/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2008 - 09/2006
1	Butyrates (Butyrate)IBA 10/2019
1	Butyric Acid (Butanoic Acid)IBA 10/2019
1	Adalimumab (Humira)FDA Link 01/2019
1	Infliximab (Remicade)FDA Link 01/2019
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	AlbuminsIBA 01/2019
1	Volatile Fatty AcidsIBA 12/2018
1	Rifaximin (L 105)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 05/2017
1	Lactulose (Duphalac)FDA LinkGeneric 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Proton Pump InhibitorsIBA 01/2015
1	Pattern Recognition ReceptorsIBA 09/2014
1	Antimicrobial PeptidesIBA 09/2014
1	NucleotidesIBA 02/2014
1	LigandsIBA 01/2012
1	InterferonsIBA 01/2012
1	AS 8IBA 02/2010
1	Indicators and Reagents (Reagents)IBA 12/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2008
1	Complement System Proteins (Complement)IBA 07/2007
1	Proteins (Proteins, Gene)FDA Link 07/2007
1	Monoclonal AntibodiesIBA 05/2007
1	Immunoglobulins (Immunoglobulin)IBA 05/2007

Therapy/Procedure

2	Ligation 01/2020 - 10/2014
2	Oral Administration 06/2019 - 01/2018
2	Therapeutics 07/2015 - 02/2014
1	Immunotherapy 01/2021
1	Immunomodulation 01/2020
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2019
1	Liver Transplantation 01/2019
1	Biological Therapy 02/2014
1	Laparotomy 05/2007